MXPA02012907A - Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad. - Google Patents

Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.

Info

Publication number: MXPA02012907A
Authority: MX; Mexico
Prior art keywords: prophylaxis; obesity; treatment; locating; compounds
Prior art date: 2000-07-20

Application number

MXPA02012907A

Other languages

English (en)

Inventor

Antel Jochen

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-20

Filing date

2001-07-12

Publication date

2003-09-22

2001-07-12 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

2003-09-22 Publication of MXPA02012907A publication Critical patent/MXPA02012907A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Biotechnology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

MXPA02012907A 2000-07-20 2001-07-12 Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad. MXPA02012907A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10035227A DE10035227A1 (de)	2000-07-20	2000-07-20	Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de)	2000-07-20	2001-07-12	Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (1)

Publication Number	Publication Date
MXPA02012907A true MXPA02012907A (es)	2003-09-22

Family

ID=7649538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02012907A MXPA02012907A (es)	2000-07-20	2001-07-12	Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.

Country Status (26)

Country	Link
EP (1)	EP1307262B1 (es)
JP (1)	JP2004504053A (es)
KR (1)	KR100818827B1 (es)
CN (1)	CN1443085B (es)
AR (1)	AR028730A1 (es)
AT (1)	ATE278441T1 (es)
AU (2)	AU2001277534B9 (es)
BR (1)	BR0112547A (es)
CA (1)	CA2416647A1 (es)
CZ (1)	CZ2003156A3 (es)
DE (2)	DE10035227A1 (es)
DZ (1)	DZ3393A1 (es)
ES (1)	ES2230346T3 (es)
HU (1)	HUP0302309A3 (es)
IL (2)	IL153971A0 (es)
MX (1)	MXPA02012907A (es)
NO (1)	NO20030233L (es)
NZ (1)	NZ523960A (es)
PL (1)	PL201165B1 (es)
PT (1)	PT1307262E (es)
RU (1)	RU2268721C2 (es)
SK (1)	SK287607B6 (es)
TR (1)	TR200402670T4 (es)
TW (1)	TWI274157B (es)
UA (1)	UA74588C2 (es)
WO (1)	WO2002007821A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2567166A1 (en)	2004-05-19	2005-11-24	Solvay Pharmaceuticals Gmbh	Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
MY147767A (en)	2004-06-16	2013-01-31	Janssen Pharmaceutica Nv	Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (en)	2005-05-20	2008-01-30	Janssen Pharmaceutica N.V.	Process for preparation of sulfamide derivatives
AR057570A1 (es)	2005-11-14	2007-12-05	Solvay Pharm Gmbh	Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8497298B2 (en)	2005-12-19	2013-07-30	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en)	2005-12-19	2014-05-06	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en)	2005-12-19	2014-04-08	Janssen Pharmaceutica Nv	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8492431B2 (en)	2005-12-19	2013-07-23	Janssen Pharmaceutica, N.V.	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8937096B2 (en)	2005-12-19	2015-01-20	Janssen Pharmaceutica Nv	Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
AU2007253814A1 (en)	2006-05-19	2007-11-29	Janssen Pharmaceutica N.V.	Co-therapy for the treatment of epilepsy
EP2106260B8 (en)	2007-01-25	2018-04-04	Naia Metabolic, Inc.	Insulin sensitisers and methods of treatment
WO2010008776A2 (en)	2008-06-23	2010-01-21	Janssen Pharmaceutica Nv	Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8815939B2 (en)	2008-07-22	2014-08-26	Janssen Pharmaceutica Nv	Substituted sulfamide derivatives
SG10201705388XA (en) *	2012-05-24	2017-07-28	Verva Pharmaceuticals Ltd	A Method Of Improving Liver Function
CN106770611B (zh) *	2016-12-22	2019-01-29	广西师范大学	一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) *	2021-09-21	2022-05-04	Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН)	Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4552897A (en) *	1983-02-01	1985-11-12	American Cyanamid Company	Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) *	1987-09-04	2001-09-11	Beecham Group P.L.C.	Compounds
US4952567A (en) *	1988-05-09	1990-08-28	City Of Hope	Inhibition of lipogenesis
US5126324A (en) *	1990-06-07	1992-06-30	Genentech, Inc.	Method of enhancing growth in patients using combination therapy
ZA932660B (en) *	1992-04-17	1993-10-26	Sankyo Co	Derivatives of adipogenesis inhibitory factor, their preparation and their use
DE69305091T2 (de) *	1992-10-29	1997-03-13	Genentech Inc	Methode zur behandlung oder verhütung von fettleibigkeit
AU693478B2 (en) *	1994-11-10	1998-07-02	Metabolic Pharmaceuticals Limited	Treatment of obesity
SK284305B6 (sk) *	1996-06-28	2005-01-03	Ortho-Mcneil Pharmaceutical, Inc.	Liečivo na liečbu obezity
US5727570A (en) *	1996-11-14	1998-03-17	Clemens; Anton H.	Method of treating hyperlipidemia in humans
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor

2000
- 2000-07-20 DE DE10035227A patent/DE10035227A1/de not_active Withdrawn
2001
- 2001-06-15 AR ARP010102883A patent/AR028730A1/es unknown
- 2001-07-12 CZ CZ2003156A patent/CZ2003156A3/cs unknown
- 2001-07-12 PL PL363518A patent/PL201165B1/pl not_active IP Right Cessation
- 2001-07-12 CN CN018129730A patent/CN1443085B/zh not_active Expired - Fee Related
- 2001-07-12 KR KR1020037000620A patent/KR100818827B1/ko not_active Expired - Fee Related
- 2001-07-12 AT AT01955345T patent/ATE278441T1/de active
- 2001-07-12 JP JP2002513551A patent/JP2004504053A/ja active Pending
- 2001-07-12 PT PT01955345T patent/PT1307262E/pt unknown
- 2001-07-12 HU HU0302309A patent/HUP0302309A3/hu unknown
- 2001-07-12 ES ES01955345T patent/ES2230346T3/es not_active Expired - Lifetime
- 2001-07-12 EP EP01955345A patent/EP1307262B1/de not_active Expired - Lifetime
- 2001-07-12 WO PCT/EP2001/008051 patent/WO2002007821A1/de not_active Ceased
- 2001-07-12 RU RU2003104803/14A patent/RU2268721C2/ru not_active IP Right Cessation
- 2001-07-12 SK SK61-2003A patent/SK287607B6/sk not_active IP Right Cessation
- 2001-07-12 DE DE50104023T patent/DE50104023D1/de not_active Expired - Lifetime
- 2001-07-12 AU AU2001277534A patent/AU2001277534B9/en not_active Ceased
- 2001-07-12 AU AU7753401A patent/AU7753401A/xx active Pending
- 2001-07-12 CA CA002416647A patent/CA2416647A1/en not_active Abandoned
- 2001-07-12 DZ DZ013393A patent/DZ3393A1/xx active
- 2001-07-12 MX MXPA02012907A patent/MXPA02012907A/es active IP Right Grant
- 2001-07-12 IL IL15397101A patent/IL153971A0/xx unknown
- 2001-07-12 NZ NZ52396001A patent/NZ523960A/xx not_active IP Right Cessation
- 2001-07-12 BR BR0112547-8A patent/BR0112547A/pt not_active Application Discontinuation
- 2001-07-12 TR TR2004/02670T patent/TR200402670T4/xx unknown
- 2001-07-16 TW TW090117382A patent/TWI274157B/zh not_active IP Right Cessation
- 2001-12-07 UA UA2003021453A patent/UA74588C2/uk unknown
2003
- 2003-01-15 IL IL153971A patent/IL153971A/en not_active IP Right Cessation
- 2003-01-17 NO NO20030233A patent/NO20030233L/no unknown

Also Published As

Publication number	Publication date
JP2004504053A (ja)	2004-02-12
RU2268721C2 (ru)	2006-01-27
TR200402670T4 (tr)	2004-11-22
EP1307262B1 (de)	2004-10-06
NO20030233D0 (no)	2003-01-17
HK1057499A1 (zh)	2004-04-08
NZ523960A (en)	2004-12-24
AU2001277534B9 (en)	2006-02-23
PT1307262E (pt)	2004-12-31
SK612003A3 (en)	2003-06-03
ES2230346T3 (es)	2005-05-01
DZ3393A1 (fr)	2002-01-31
HUP0302309A3 (en)	2005-06-28
IL153971A (en)	2009-07-20
CN1443085A (zh)	2003-09-17
HUP0302309A2 (hu)	2003-11-28
PL201165B1 (pl)	2009-03-31
BR0112547A (pt)	2003-07-01
IL153971A0 (en)	2003-07-31
TWI274157B (en)	2007-02-21
AR028730A1 (es)	2003-05-21
UA74588C2 (en)	2006-01-16
CA2416647A1 (en)	2003-01-20
CN1443085B (zh)	2010-04-28
SK287607B6 (sk)	2011-03-04
KR100818827B1 (ko)	2008-04-01
EP1307262A1 (de)	2003-05-07
NO20030233L (no)	2003-03-19
ATE278441T1 (de)	2004-10-15
KR20030022284A (ko)	2003-03-15
PL363518A1 (en)	2004-11-29
CZ2003156A3 (cs)	2003-06-18
WO2002007821A1 (de)	2002-01-31
DE10035227A1 (de)	2002-01-31
AU2001277534B2 (en)	2005-09-29
DE50104023D1 (de)	2004-11-11
AU7753401A (en)	2002-02-05

Publication	Publication Date	Title
PL364995A1 (en)	2004-12-27	Method for the treatment or prevention of flavivirus
AU8870701A (en)	2002-03-13	Materials and methods for the treatment or prevention of obesity
PL369237A1 (en)	2005-04-18	Micro-organisms for the treatment of soil and process for obtaining them
MXPA03007960A (es)	2003-12-04	Compuestos y metodos para el tratamiento de desordenes urogenitales.
GB0512558D0 (en)	2005-07-27	Microorganisms for well treatment
HUP0302739A3 (en)	2012-09-28	Method for the treatment of tobacco
EP1337255A4 (en)	2006-01-25	USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH
MXPA02012907A (es)	2003-09-22	Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.
GB0129976D0 (en)	2002-02-06	Treatment method
AU2001277534A1 (en)	2002-05-02	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
EP1465968A4 (en)	2005-12-14	METHODS OF TREATING DISTILLATE DEODORIZER
MXPA03001717A (es)	2003-09-22	METODO PARA EL TRATAMIENTO DE LA MIGRAnA.
AU2003263760A1 (en)	2004-01-19	Methods for the treatment or prevention of obesity
AU2002364171A8 (en)	2003-06-30	Materials and methods for the treatment or prevention of obesity
AP2004003070A0 (en)	2004-06-30	The method of treating cancer.
AU7750100A (en)	2001-04-23	Method for the treatment of obesity
GB0120147D0 (en)	2001-10-10	Treatment method
MXPA03004017A (es)	2004-02-12	Metodo para el tratamiento de inflamacion.
AU6137801A (en)	2001-11-20	Method and composition for the treatment of angiogenesis
SG102679A1 (en)	2004-03-26	Surface treatment method and material treated by the method
ZA200101058B (en)	2001-09-05	Process for the treatment of gases.
GB0026838D0 (en)	2000-12-20	Treatment method
GB0008921D0 (en)	2000-05-31	Method of treatment
MXPA03002280A (es)	2003-09-10	Proceso para purificacion de isooctano y/o diisobutileno.
SI1307262T1 (en)	2005-02-28	Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Legal Events

Date	Code	Title	Description
2007-01-08	FG	Grant or registration